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Impaired olfaction is an early symptom in Parkinson disease (PD), although the exact cause is as yet
unknown. Here, we investigated the link between PD-related mutant a-Synuclein (a-SYN) pathology and
olfactory deficit, by examining the integration of adult-born neurons in the olfactory bulb (OB) of A30P
a-SYN overexpressing mice. To this end, we chose to label one well-known vulnerable subpopulation of
adult-born cells, the dopaminergic neurons. Using in vivo two-photon imaging, we followed the dynamic
process of neuronal turnover in transgenic A30P a-SYN and wild-type mice over a period of 2.5 months.
Our results reveal no difference in the number of cells that reach, and possibly integrate into, the glomerular
layer in the OB. However, in mutant transgenic mice these new neurons have a significantly shortened
survival, resulting in an overall reduction in the addition of neurons to the glomerular layer over time. We
therefore propose unstable integration and impaired homeostasis of functional new neurons as a likely
contributor to odour discrimination deficits in mutant a-SYN mice.
H
yposmia is one of the most frequent non-motor symptoms of Parkinson disease (PD)1–3, being detected in
the majority of PD patients several years before the first appearance of motor symptoms4. Moreover,
deposition of fibrillar a-synuclein (a-SYN) aggregates5,6 - the main pathological hallmark of the disease -
occurs inside olfactory bulb (OB) neurons of PD patients7,8. Despite evidence of olfactory deficits in a-SYN
overexpressing mice9, no satisfactory explanation has yet been put forward which correlates the neuropatholo-
gical findings with the behavioural deficit. Interestingly, a deficit of neuronal precursor cells was discovered in the
OB of PD patients compared with healthy controls10. Studies in mice further linked a-SYN overexpression to
reduced survival of adult-born OB neurons11–14, including both periglomerular neurons (PGNs) and granule cells
(GCs). Despite the evidence gained from these studies, we still lack a thorough investigation of the long-term
effects of a-SYN aggregates on this highly dynamic process of neuronal turnover which occurs in the OB15.
Undoubtedly, continuous incorporation of ‘virgin’ neurons into pre-existing networks poses a considerable
physiological challenge, since their survival depends very much on the activity of local circuits and extrinsic
influences16–20. Functional synaptic plasticity and integration requires communication with network neurons at
the integration site and is a prerequisite for their contribution to olfactory circuits21–23. For instance, by synapsing
with mitral cells (MCs), adult-born neurons sharpen odour tuning and provide contrast enhancement, important
determinants for odour discrimination24,25. It is thus not surprising that this complex, fine-tuned, turnover of
gained-and-lost neurons is closely coupled with olfactory stimulation22. Thus, odour deprivation decreases the
number of new neurons in the OB19, whereas odour enrichment promotes their survival20.
In our study, we aimed at correlating PD-related a-SYN pathology in the OB network with olfactory deficits
and the fate of adult-born neurons. To this end, we investigated in detail the a-SYN pathology in the OB of A30P
a-SYN mice26 and its impact on olfaction. Using chronic intravital two-photon imaging, we followed the turnover
of adult-born neurons in the OB of transgenic a-SYN and wild-type mice over a period of 2.5 months. We focused
on dopaminergic PGNs as a subset of adult-born neurons, because (i) these are known to be primarily affected in
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Herein, we report that aggregation-prone A30P a-SYN interferes
with the stable integration and longer-term survival of adult-born
neurons, with possible consequences on odour discrimination.
Results
A30P a-SYN mice are impaired in fine odour discrimination. For
the initial characterization of PD-related pathology, we examined a-
SYN aggregation in the OB of 6-month-old mice overexpressing
human A30P a-SYN under the Thy1-promoter26. The A30P muta-
tion is known to cause severe, early-onset familial PD, accelerating
the formation of toxic protein protofibrils29,30. Immunofluorescent
staining with human a-SYN-specific antibody 15G731 revealed broad
protein expression throughout the OB network including its three
main cell layers: glomerular, MC and GC layer (Fig. 1a). In
comparison to mice with elevated a-SYN levels in neuroblasts and
immature newborn cells (PDGFb-promoter)11,12, protein expression
under neuron-specific Thy126,32 starts relatively late, thus providing a
suitable model for the study of neuronal integration and fate in a-
SYN-loaded networks in early-stage PD33.
In PD, a-SYN is post-translationally modified (glycated, nitrated,
oxidized or phosphorylated) and thereby more prone to forming
aggregates and fibrils34. Thus, we characterized one form of patho-
logical protein alteration by staining against phosphorylated a-SYN,
a major component of Lewy bodies (LB) in the human brain35. In
transgenic, but not wild-type, mice phosphorylated a-SYN was
detected in the wide majority of MCs (Fig. 1b,d), while the glom-
erular (Fig. 1c) and GC layers (Fig. 1e) were largely spared36. In
addition, a-SYN was characterized by its resistance to proteinase K
(PK) digestion, a property shared in common with fibrillar amyloid-
b, the major component of Alzheimer disease-related amyloid pla-
ques, and with the disease-associated form of prion protein5. a-SYN
clusters were detected in some MCs of the transgenic mice (Fig. 1f,h)
but were absent from wild-type mice. Rarely, we detected subcellular
a-SYN accumulations in the glomerular (Fig. 1g) and GC layer
(Fig. 1i) of mutant a-SYN mice. These findings in Thy1-A30P a-
Figure 1 | Olfactory bulb pathology in A30P a-SYN mice. (a) Immunofluorescent micrographs showing the overexpression pattern of human A30P a-
SYN (15G7, red) under control of the Thy1-promoter in the OB of 6-month-old transgenic mice: z-stack projections of confocal series. Scale bar - 50 mm.
(b–e) Representative OB sections immunostained for phosphorylated a-SYN (pSer129, DAB), a marker for aberrant protein modification. Scale bars -
50 mm. (b) Distribution of phosphorylated a-SYN in (c) PGNs, (d) MCs and (e) GCs. Note that only MCs are positive for pSer129. (f–j) Representative
OB sections with immunostaining for fibrillar protein, detected by Proteinase K digestion and human a-SYN specific antibody (15G7, DAB). Scale bars -
50 mm. Images with higher magnification of the (g) glomerular, (h) MC and (i) GC layer. Some a-SYN aggregates were detected in MCs of transgenic, but
not wild-type, mice. (j) Olfactory discrimination task. Six-month-old Control (wild-type) (n 5 8) and A30P a-SYN mice (n 5 7) were exposed to
different binary odour mixtures (e.g. 55% S1 and 45% S2 vs. 45% S1 and 55% S2). Mice were trained to dig in a bowl containing more of S1 odour.
Correct choices for S1 were plotted against the different mixture pairs. Note that with increasing similarity of the mixtures, the performance of A30P a-
SYN mice dropped compared to Control. (k) Olfactory memory task. **p , 0.01; ***p , 0.005; two-way ANOVA/Bonferroni post-hoc test.
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SYN mice thus reflect in part the neuropathology in the human PD
brain, showing LBs in MCs and the inner plexiform layer7.
We further tested whether a-SYN accumulation in the OB is
associated with olfactory deficits in the transgenic mice. To this
end, we used a simple battery test37,38 which allows the detection of
subtle differences in olfactory discrimination. Mice had to choose
between increasingly similar solutions consisting of a mixture of two
different odours (conditioned S1; S2), down to concentration differ-
ences of only 2% (Fig. 1j). Up to a 10% difference (55% S1 and 45%
S2; vice versa), A30P a-SYN mice performed just as wild-type
Control. However, at mixtures with 6% difference (53% S1 and
47% S2; vice versa) the performance of PD-like mice dropped sig-
nificantly when compared to Control (75 6 8%, n 5 7 mice vs. 89 6
8%, n 5 8 mice, respectively; p , 0.01). This discrepancy between the
two genotypes grew markedly with the next difficulty step. Whereas
wild-type mice managed to discriminate 2% different odorant mix-
tures (51% S1 and 49% S2; vice versa) in 93 6 8% of the trials, a-SYN
mice succeeded in only 79 6 9% (p , 0.001). As expected, 50%
binary mixtures could not be distinguished by either group, with
correct choices being close to the chance level of 50% (i.e. random).
Importantly, during training and conditioning, a-SYN and Control
mice behaved and learned equally to discriminate S1 from S2 (aver-
age success rate of 90 6 8%, respectively; p . 0.05). These results
therefore indicate that 6 month-old A30P a-SYN mice are impaired
in fine, but not in pure and general odour discrimination. To test for
effects of a-SYN on olfactory long-term memory22, we confronted
the mice with the different odours again after 2 months (Fig. 1k).
Both genotypes recalled the test in the same way, showing that olfact-
ory memory was not adversely affected by aggregation-prone A30P
a-SYN.
Adult-born dopaminergic neurons are vulnerable to A30P a-SYN
deposition. As an important aim of our study, we investigated the
impact of A30P a-SYN accumulation on the dynamic integration
process of adult-born neurons. Due to their superficial location in the
OB and their particular role in PD27,28, we chose one subset of adult-
born neurons: dopaminergic PGNs, which constitute ,20–40% of all
GABAergic PGNs39–41. In the glomerular layer of the transgenic a-
SYN mice, A30P a-SYN was enriched in both tyrosine hydroxylase
(TH)-positive dopaminergic neurons and other PGN subtypes
(Fig. 2a). Notably, A30P a-SYN had a significant impact on the
density of TH-positive PGNs in both 6- (,30%; 16,000 6 1,700
vs. 23,000 6 1,700 neurons per mm3; n 5 4 mice per group; p ,
0.05) and 12-month-old transgenic mice (,47%; 16,100 6 1,900 vs.
30,200 6 2,600; n 5 3 mice per group) when compared to Control
(p , 0.05; Fig. 2b). While the dopaminergic neuron density remained
on a similar level in transgenic a-SYN mice of both ages (p . 0.05), a
clear trend towards an increase in these neurons was apparent in
wild-type mice from 6 to 12 months (p 5 0.06), consistent with
previous reports15. Collectively, these results demonstrate a
sensitivity of dopaminergic PGNs to toxic A30P a-SYN in the PD
mouse model.
To confirm the negative effect of A30P a-SYN deposition on the
survival of newborn dopaminergic PGNs, we performed BrdU-injec-
tions (Fig. 2c–e). Of note, A30P a-SYN mice showed ,50% reduc-
tion of the total new PGNs after 1 month (0.9 6 0.01%; n 5 6 mice
vs. 1.8 6 0.3% in Control; n 5 5 mice; p , 0.05) (Fig. 2d), whereas
cell proliferation was not affected (p . 0.05; not shown). Similar
analysis in the GC layer revealed a comparable result: ,45% less
adult-born GCs in the PD-like mice (2.0 6 0.1%; n 5 6 vs. 3.6 6
0.5% in Control; n 5 5) (p , 0.01; not shown). The fraction of
newborn dopaminergic PGNs, characterized by co-expressing of
TH and BrdU, was decreased to ,33% in the PD-like mice (27.7
6 3.8%; n 5 4 mice/97 cells vs. 41.6 6 3.4%; n 5 3 mice/91 cells,
respectively; p , 0.05) (Fig. 2e). As expected, the loss of dopaminergic
adult-born PGNs was less than in PDGFb-human A53T a-SYN
mice12 (70%), PDGFb-human wild-type a-SYN mice11 (59%), and
CaMK-human A30P a-SYN mice13 (41%). Together, these results
confirm the reduced survival of adult-born PGNs and GCs in the
OB of A30P a-SYN mice, with the dopaminergic PGNs as one vul-
nerable subpopulation.
Genetic labelling of dopaminergic neurons in A30P a-SYN mice.
To specifically target dopaminergic PGNs for the in vivo study in a-
SYN mice, we established a Cre/lox mouse model of PD (Fig. 3a). We
first crossed knock-in driver lines expressing Cre recombinase from
the TH locus (TH::IRES-Cre)42 with tdTomato reporter mice43. These
double-transgenic wild-type mice were referred to as TH-Control.
Further crossing to Thy1-human A30P a-SYN mice26 enables the
analysis of dopaminergic neurons with PD-like phenotype, cited as
TH-A30P a-SYN. Previous studies reported a non-specific leak in
this Cre/lox system15,43. To test the accuracy of genetic labelling of
dopaminergic neurons within the glomerular layer of TH-Control
and TH-A30P a-SYN mice (9-month-old), we stained OB sections
with antibodies against TH and two other PGN markers39, Calbindin
(CB) and Calretinin (CR) (Fig. 3b–d). In accordance with Adam and
Mizrahi15, we detected tdTomato expression in the GC and MC layer
(Fig. 3b), regions in which neurons normally do not express TH.
Around the glomeruli, quantification of single and double-labelled
neuronal somata expressing tdTomato with or without marker
(Fig. 3c,d), revealed a majority of 71.0 6 4.8% tdTomato-positive
cells expressing simultaneously TH (n 5 3 mice/1,698 cells). A
very small proportion of tdTomato cells expressed CR (5.0 6 7.5%;
n 5 4 mice/2,752 cells), while nearly none expressed CB (0.3 6 0.2%;
n 5 4 mice/2,313 cells). To confirm stability of this labelling system
within the time window for two-photon imaging, we compared these
results to 12-month-old mice, revealing similar levels of tdTomato-
positive cells expressing TH (69.9 6 2.6%; n 5 2 mice/226 cells; p .
0.05). Overall, these findings are similar to previous reports15 using
heterozygous Z/EG GFP Cre reporter mice for the labelling of
dopaminergic PGNs. Two months after transduction of new
neurons with lentiviral (LV) eGFP constructs41,44 in the rostral
migratory stream (RMS), we observed a small fraction of cells
being positive for both eGFP and tdTomato (Fig. 3e), confirming
that the TH-A30P a-SYN mouse labels adult-born dopaminergic
PGNs. In conclusion, we consider this Cre/lox system appropriate
for the genetic targeting of dopaminergic PGNs in the OB of
transgenic a-SYN mice.
A30P a-SYN interferes with the stable integration of adult-born
dopaminergic neurons in vivo. To monitor the dynamic integration
and fate of the adult-born PGNs in vivo, we implanted an open-skull
cranial window over both OBs (Fig. 4a–d). In line with previous
reports for the OB15 and cortex45, we achieved with our preparation
a success rate of ,60% usable windows for high-quality microscopy.
Optical clarity for intravital two-photon imaging remained stable
throughout the test period of 2.5 months. As open-skull surgery is
associated with activation of glial cells in the OB15 and cortex46 within
the first three weeks after operation, we started imaging 4 weeks post
operatively to avoid the potential impact of gliosis on the analysis
(Fig. 4e). Chronic imaging was performed in 9-month-old TH-A30P
a-SYN and aged-matched TH-Control mice. Assuming a continuous
neuronal turnover, we chose this time frame to elucidate in more
detail the lack of dopaminergic PGNs observed in 6- and 12-month-
old transgenic a-SYN mice (Fig. 2b). Because differentiation into the
final fate of adult-born neurons requires synaptic contacts23,47, the
appearance of tdTomato-labelled cell bodies indicated synaptic
integration of newborn dopaminergic PGN, whereas disappearance
of red somata clearly displayed the death of these neurons within the
interneuron network15,48 (Fig. 4f,g). Accordingly, all the stable, lost or
gained PGNs were tracked in a 2-week interval as summarized in
Fig. 4h. In both genotypes, the neuron turnover rates were similar
(0.8 6 0.1; n 5 4 mice/1,454 cells and 0.6 6 0.2; n 5 5 mice/1,437
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cells; PD-like and Control, respectively) (p . 0.05; not shown). Of
note, in TH-Control mice more PGNs gradually added to the
network as assessed relative to the first imaging time point
(Fig. 4i), resulting in a steady increase of these neurons up to 16.1
6 5.5% after 2.5 months (p , 0.01). This continuous enlargement of
the dopaminergic PGN population in wild-type mice both confirms
our results shown in Fig. 2b and accords with a previous study of
dopaminergic neuron turnover15. In contrast, in TH-A30P a-SYN
mice the number of PGNs marginally decreased over time to 23.8
6 2.4%, but statistically remained on the same level (Fig. 4i; p .
0.05). Comparison of the fractional changes in the neuron density of
both genotypes revealed significant differences at the last two time
points (p , 0.05 and p , 0.01, respectively). In addition, we
determined the percentage of stable, lost and gained PGNs per
imaging interval in both groups (Fig. 4k–m). Interestingly, both
genotypes showed similar fractions of gained PGNs (Fig. 4l; 10.2 6
1.4% vs. 10.7 6 0.9%; PD-like and Control, respectively), while a
significant increase in lost PGNs was recorded in the transgenic a-
SYN mice (Fig. 4m; 11.4 6 1.1% vs. 7.6 6 1.0%; p , 0.05). To
determine the timing of cell loss, we further quantified the fraction
of cells that appeared at one imaging time point, but quickly
disappeared in the next, as a parameter for integration stability
(Fig. 4n). This readout further provides novel insight into the
temporal definition of the toxic effect of A30P a-SYN. Notably,
TH-A30P a-SYN mice showed more than double the amount of
‘short-lived’ cells per imaging interval compared to TH-Control
(28.2 6 1.2% vs. 12.7 6 3.9%; p , 0.05). The higher neuron loss
in PD-like mice was also reflected in a lower fraction of stable
neurons (86.6 6 2.7% vs. 92.2 6 0.8%) (p 5 0.06; Fig. 4k) and a
23% decrease in the overall survival rate over time (Fig. 4j). Indeed,
Figure 2 | Reduced survival of adult-born periglomerular neurons in A30P a-SYN mice. (a1) Immunofluorescent micrographs demonstrating tyrosine
hydroxylase (TH, green) and human A30P a-SYN (15G7, red) expression in the various OB layers in transgenic a-SYN mice: z-stack projections of
confocal series. Scale bar - 50 mm. Note that TH expression is restricted to the glomerular layer. (a2) Representative higher magnification images of one
glomerulus shows accumulation of human A30P a-SYN in dopaminergic neurons (white arrows) and other PGN subtypes (white asterisks) in A30P a-
SYN mice, whereas Control mice lack the expression of human a-SYN. Scale bar - 20 mm. (b) Summary plots showing the density of TH-positive neurons
per mm3 OB in 6- and 12-month-old Control (n 5 8) and A30P a-SYN mice (n 5 8). (c) Representative immunofluorescent micrographs of adult-born
(BrdU, green) dopaminergic (TH, red) neurons: z-stack projections of confocal series. Double-labelled cells (yellow arrow) represent a small fraction of
the generally low number of BrdU-positive PGNs. Scale bar - 20 mm. (d) Summary plots demonstrating the percentage of adult-born (BrdU) PGNs
(NeuN) amongst all PGNs one month after their birth in 6-month-old Control (n 5 4) and A30P a-SYN mice (n 5 3). (e) Summary plots showing the
fraction of dopaminergic (TH) adult-born (BrdU) PGNs in Control (n 5 4) and A30P a-SYN mice (n 5 3) of the same age. *p , 0.05; Student’s t-test.
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while 70.9 6 5.5% PGNs, counted in TH-Control at the first time
point, were still preserved after 2.5 months, this number was reduced
to 54.7 6 8.3% in TH-A30P a-SYN mice (p , 0.05). In conclusion,
this detailed turnover analysis reveals deleterious consequences of
A30P a-SYN on the stable incorporation of new PGNs, which
reach the glomerular layer and appear to integrate into the
abnormal ’diseased’ network but are eliminated shortly afterwards.
Discussion
Our study provides the first in vivo evidence that A30P a-SYN accu-
mulation interferes with the stable integration of the adult-born
neurons in the OB, with significant effects on their survival. As
summarized in Fig. 5, we describe a progressive increase in cell loss
in the transgenic mutant a-SYN mice (,12%) as compared to wild-
type (,8%), while at the same time the gain in new neurons is similar
in both groups (,10%). Of note, this neuronal loss specifically tar-
gets those cells which have been recently integrated in the network.
Such data demonstrates that early stages of incorporation and dif-
ferentiation into dopaminergic neurons are not affected in transgenic
Thy1-A30P a-SYN mice. Rather, it is their longer-term consistency
and survival within the OB network which is defective, resulting in an
overall reduction in the net addition of neurons to the OB over time.
Consequently, PD-like mice lack the successful substitution of pre-
existing adult-born neurons with new functional cells. Maintaining a
stable, and precise, equilibrium between the influx of new neurons
and the elimination of old neurons represents a key determinant of
olfactory discrimination49. We therefore propose a disturbed neur-
onal plasticity resulting from unstable integration of adult-born
PGNs and GCs in A30P a-SYN mice, as a probable contributing
factor to the observed olfactory discrimination deficits.
Furthermore, with this chronic, intravital two-photon imaging
study of the integration kinetics of new neurons in transgenic a-
SYN mice, we have also developed a potentially useful platform for
the testing and evaluation of drugs that promote the integration and
survival of neurons against a-SYN-induced toxicity. For this pur-
pose, the OB is ideal since it is located superficially and thus easy to
access15, whist representing at the same time the second main source
of dopaminergic neurons in the brain50. We studied this subset of
adult-born neurons as representative of a vulnerable population of
interneurons. Their susceptibility to increased amounts of a-SYN
Figure 3 | Genetic labelling of dopaminergic neurons in the olfactory bulb of A30P a-SYN mice. (a) Crossing scheme for targeting dopaminergic
neurons in PD-like (top) and Control (wild-type; bottom) mice. Mice with Cre recombinase knocked into the TH locus were crossed to Ai9 tdTomato
Cre reporter (TH-Control); and further to human A30P a-SYN mice (TH-A30P a-SYN). (b) Immunofluorescent micrographs showing tdTomato (red)
and TH (green) expression in various OB layers in TH-A30P a-SYN mice, including ‘Merge’ view: z-stack projections of confocal series. Scale bar - 50 mm.
(c) Representative high magnification images of one glomerulus with tdTomato-positive PGNs, stained for various subtype markers (c1) TH, (c2)
calbindin (CB) or (c3) calretinin (CR) (green): z-stack projections of confocal series. White arrows point to double-labelled cells (Merge, yellow). Scale
bar - 20 mm. (d) Summary plots showing the percentage of single/double-labelled PGN somata in TH-A30P a-SYN mice, expressing tdTomato with or
without TH, CR and CB. TH from tdTomato, 71.0 6 4.8% of tdTomato-positive cells expressed TH; tdTomato from TH, 98.0 6 0.4% of TH cells
expressed tdTomato (n 5 1,698 cells from 3 mice); CB from tdTomato, 0.3 6 0.2% of tdTomato-positive cells expressed CB (n 5 2,313 cells from 4 mice);
CR from tdTomato, 5.0 6 7.5% of tdTomato-positive cells expressed CR (n 5 2,752 cells from 4 mice). (e) High-resolution micrograph of a 2-month-old
lentivirally-labelled (LV-eGFP; green) dopaminergic (tdTomato; red) adult-born PGN in TH-A30P a-SYN mice: z-stack projections of in vivo two-
photon series. Scale bar - 20 mm.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 3931 | DOI: 10.1038/srep03931 5
had been demonstrated by several other studies, analysing variously
proliferation, differentiation, survival and signalling of dopaminergic
PGNs11–14,28. A possible explanation for the vulnerability of dopami-
nergic neurons involves increased cellular toxicity in the presence of
dopamine51. Other groups report on the role of a-SYN in regulating
dopamine biosynthesis, which is disturbed upon a-SYN aggrega-
tion52. We further showed that increased cell death is not a unique
feature of dopaminergic adult-born PGNs but appears also in other
integrating neurons, because adult-born GCs were affected similarly
in our PD mouse model as well as in others11–14.
The observed effects on the sensitive, newly-integrating neurons
could originate from different sources, namely (i) intracellular a-
SYN toxicity, or (ii) extrinsic influence from the a-SYN loaded net-
work/a-SYN pathology in MCs. The latter possibility implicates that
a-SYN accumulation in the OB network is likely to alter the synaptic
activity of the neuronal circuit. During maturation and integration,
roughly between 10 and 60 days after birth, adult-born neurons
establish synapses with existent neurons21,23. Thereafter, cells may
remain stable for up to 19 months, indicating long-term survival of
the adult-born cells47. Our study specifically reveals that the critical
step between early and stable integration/survival of the adult-born
neurons, which depends on neuronal input and activity16, is affected
by A30P a-SYN aggregation. In favour of the altered network hypo-
thesis, we show that transgenic A30P a-SYN mice are characterized
by broad a-SYN accumulation in the OB, while only MCs - the main
synaptic partners of adult-born PGNs and GCs25 - have pathology-
associated a-SYN modifications36. Interestingly, Thy1 expression in
the OB starts in MCs53, and transgene expression under Thy1
increases with neuron maturation32,53. We thus attribute the specific
location of the a-SYN pathology in MCs to their stability within the
OB network, allowing gradual accumulation and deposition of the
protein, whereas dynamic populations of PGNs and GCs are con-
stantly replaced during adult neurogenesis. Indeed, this a-SYN phos-
phorylation in MCs could present also a protective mechanism
against the increasing amount of more soluble protein species (e.g.
monomers, oligomers) as postulated recently by Oueslati et al.54.
Notably, both dopaminergic PGNs (and GCs) lack the aggregated/
phosphorylated form of a-SYN, but still get lost. From maturation
on, these cells contain high amounts of human a-SYN with a point
mutation which is known to accelerate the association into toxic
oligomers29,30. These mediate intracellular a-SYN toxicity - a widely
accepted disease mechanism27 - especially during the critical phase of
Figure 4 | Unstable integration of dopaminergic neurons in TH-A30P a-SYN mice in vivo. (a, b) Intravital two-photon microscopy of dopaminergic
neuron turnover through a 3 mm round open-skull cranial window implanted over both OBs. Scale bar - 1 mm (a). (c) Blood vessel map of the region of
interest (black box), as defined in (a). Scale bar - 100 mm. (d) Representative micrograph of the position (white box) marked in (c) with tdTomato-labeled
dopaminergic PGNs: z-stack projection of two-photon image series. Scale bar - 10 mm. (e) Experimental time scheme of window surgery (black arrow)
followed by in vivo two-photon imaging (grey arrow heads) in a two-week interval for a period of 2.5 months. Mice were 8 month old at the time point of
surgery. Tracking of stable (red), gained (green) and lost (blue) PGNs in the (f1) first, (f2) second, and (f3) third imaging session, respectively: z-stack
projection of two-photon image series. Scale bar - 10 mm. (g1, g2) High-magnification images of tdTomato-labelled PGNs: (g2) one lost cell (blue) in
between a majority of stable somata (red) in two consecutive imaging sessions. Scale bar - 10 mm. (h) Table with absolute cell counts for stable (Nstable),
lost (Nlost), gained (Ngained) and present (Npresent) cells at various imaging time points in both genotypes. (i) Quantification of the change (in %) in the
PGN population over time relative to the first imaging session in TH-Control (n 5 5) and TH-A30P a-SYN mice (n 5 4). (j) Quantification of the
neuronal survival rate (in %) relative to the first imaging session in TH-Control (n 5 5) and TH-A30P a-SYN mice (n 5 4). Summary plots showing
the fraction of (k) stable, (l) gained, (m) lost, and (n) ‘short-lived’ neurons per imaging interval (%) in TH-Control (n 5 5) and TH-a-SYN mice (n 5 4).
Note the high fraction of ‘short-lived’ neurons in TH-A30P a-SYN mice, namely PGNs which appeared in one session but quickly disappeared in the
following. *p , 0.05, **p , 0.01; one way ANOVA/Tukey-Kramer post-hoc test (i); two-way ANOVA/Bonferroni post-hoc test (i,j); Student’s t-test
(k–n).
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synaptic integration16,17. Moreover, extracellular effects on the new
neurons by secreted protein54 are possible. Definitely, the total dosage
ofa-SYN is a significant factor to determine its toxicity in the cause of
PD55,56.
In conclusion, we demonstrate the pathological effects of aggrega-
tion-prone A30P a-SYN on the homeostatic turnover of adult-born
neurons, and on their stability and longer-term survival during integ-
ration into the OB network. Therefore, our transgenic mouse model
with late Thy1-A30P a-SYN expression reflects, in part, the patho-
logy observed in brains of PD patients with Lewy bodies in MCs of
the OB7,8, the human olfactory deficit at an early stage of the disease
process1–3 and a lack of progenitor cells10. Importantly, our results
support the previously reported association between adult neurogen-
esis and fine odour discrimination49,57,58; although we still lack the
molecular and cellular mechanism to explain olfactory deficits in
these mice59. Finally, a detailed investigation of the dendritic and
synaptic maturation of these neurons along with an analysis of their
synaptic connectivity to MCs will better our understanding of the
effects of toxic/mutant/aggregated a-SYN on odour discrimination
deficiency in transgenic a-SYN mice.
Methods
Animals. We used adult mice (5–12-month-old) that were bred and maintained in a
specified pathogen-free animal facility: transgenic mice (C57Bl6 background)
overexpressing human A30P a-SYN under control of the Thy1-promoter26 and age-
matched wild-type mice with same genetic background. For specific labeling of
dopaminergic PGNs in A30P a-SYN (1) and wild-type mice (2), the following two
lines were crossed: (1) TH::IRES-Cre driver line42xAi9 tdTomato Cre reporter line
with floxed stop codon43xA30P a-SYN line26, cited as TH-A30P a-SYN; (2)
TH::IRES-Cre driver line42xAi9 tdTomato Cre reporter line43, referred to as TH-
Control. In both lines, the floxed stop sequence is excised by the Cre enzyme and
tdTomato expression is activated only in TH-positive neurons of the F1 offspring. All
mice were kept in normal 12 h-light-dark cycle, had free access to food and water and
showed no signs of inflammation or metabolic compromise. Genotypes were
determined from mouse-tail DNA samples by PCR for tdTomato (forward primer:
CTGTTCCTGTACGGCATGG; reverse primer: GGCATT AAAGCAGCGTATCC)
and human A30P a-SYN (forward primer: ATGGATGTATTCATGAAAGG; reverse
primer: TTAGGCTTCAGGTTCGTAG). Together, n 5 58 animals were used in this
study. All procedures were in accordance with an animal protocol approved by the
University of Munich and the government of Upper Bavaria (Az. 55.2-1-54-2531-
184-09).
Immunohistochemistry and confocal microscopy. Mice were perfused
transcardially with 4% paraformaldehyde. For immunohistochemistry, the following
primary antibodies were applied to 50 mm free-floating coronal OB sections: mouse
monoclonal anti-tyrosine hydroxylase (TH) (15500), anti-calretinin (CR) (151000)
and anti-NeuN (15200) from Millipore, mouse monoclonal anti-calbindin (CB)
(15500) from Sigma, rat monoclonal anti-BrdU (15200), rabbit monoclonal pSer129
a-SYN (15500) from Abcam, and rat monoclonal antibody 15G7 against human a-
SYN (116–131) peptide MPVDPDNEAYEMPSEE (154000) from Connex31. As
secondary antibodies, we used: goat anti-mouse Alexa 488/647 (15500), rabbit anti-
rat Alexa 488/647 (15500) from Invitrogen and biotinylated rabbit anti-rat (15300)
from Dako. Enzymatic digestion using Proteinase K (PK; Roche) was employed for 8–
10 min. Peroxidase detection was applied for 8–10 min (DAB detection kit, DCS
Diagnostics). Sections were imaged at 0.75 mm pixels resolution in xy dimension and
1 mm in z dimension on a confocal microscope (Zeiss LSM 510) equipped with a 103,
253 or 403 oil objective (Zeiss). Counting of somata and nuclei was performed
manually from confocal image stacks, using Zeiss AIM software. For consistent
analysis, every tenth OB slice was used and imaged at predefined positions within the
glomerular layer.
BrdU injections. To study of the survival of adult-born neurons, 5-month-old mice
received intraperitoneal (i.p.) injections of bromodeoxyuridine (BrdU; 50 mg/kg) for
5 consecutive days, and were perfused transcardially at 32 days after the 1rst
injection11. To test possible effects of A30P a-SYN on the proliferation of new cells,
the mice received one single BrdU injection (100 mg/kg; i.p.), and were perfused after
24 hrs.
Viral injection and open-skull craniotomy. Mice were deeply anaesthetized with
ketamine/xylazine (0.13/0.01 mg/g body weight; i.p.). Additionally, dexamethasone
(6 mg/g body weight; i.p.; Sigma) was administered before surgery. Stereotaxic
injection of LV particles for the transduction of adult-born neurons was performed,
using pressure via a micropipette44. Mouse received 300 nl injection on both left and
right RMS (coordinates relative to Bregma: anterior 23.3 mm, lateral 20.8 mm,
depth 2.9 mm), where new dopaminergic neurons are predominantly generated40,41.
Lentivirus, containing the gene for eGFP, controlled by the CAG promoter (plasmids
from Dr. Stylianos Michalakis) was used at a titer of .108 infecting units ml21.
Implantation of open-skull cranial windows over both OBs was performed in eight-
month-old mice as described elsewhere15. Briefly, the skull over both OBs was cleaned
and dried. A round 3 mm craniotomy was opened over both OB hemispheres. Bone
was carefully removed and a 3 mm round cover slip (VWR) was gently placed on the
cavity and glued to the bone with thin layers of Histoacryl glue (B. Braun) and dental
cement (Cyano Veneer fast; H. Schein). For repeated imaging in a custom-made
stereotaxic stage, a 0.1 g metal bar was glued to the skull. After surgery, mice received
a subcutaneous analgesic dose of carprophen (5 mg/g body weight Rimadyl; Pfizer)
and the antibiotic cefotaxime (0.25 mg/g body weight, Pharmore) for three days.
Imaging began after a resting period of four weeks. In ,60% of the animals (9/15
mice) the brain region under the window was clear for imaging. If new bone grew
Figure 5 | Integration model for adult-born neurons in A30P a-SYN mice. (left - overview) Adult-born PGNs and GCs integrate into the pre-existing
OB network to contribute to olfactory function. In PD-like mice, new neurons face an a-SYN-loaded network (red; enhanced A30P a-SYN expression)
with a pathology-associated phenotype in MCs (-p; phosphorylated a-SYN), the central synaptic partners of both PGNs and GCs. (right - crop into the
glomerular layer) Our in vivo study of dopaminergic PGN turnover provides evidence for a shortened survival of adult-born neurons due to unstable
integration. While same fractions of cells are gained in both groups (,10%; green border), transgenic a-SYN mice show a higher cell loss (,12%) than
wild-type (,8%; broken border). Of note, this neuronal loss specifically targets those cells which have been recently integrated in the network, the ‘short-
lived’ neurons. This imbalance results in a reduction in the addition of neurons to the glomerular layer over time in PD-like mice. These data suggest that
increased a-SYN accumulation - both inside the affected cell and in the surrounding network - drastically interferes with the balanced turnover of old and
new neurons by preventing stable, longer-term integration of new neurons. An impaired homeostasis of functional new neurons represents a likely
contributor to odour discrimination deficits in A30P a-SYN mice.
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under the window and impeded high-quality imaging, mice were excluded from the
study.
In vivo two-photon imaging. Imaging was performed under light anaesthesia
(ketamine/xylazine, 0.1/0.0075 mg/g body weigh, i.p). Mice were placed under the
microscope in a custom-made holder with fixed position relative to the objective lens.
Two-photon imaging data presented here were from 6 consecutive imaging sessions
from 9 mice. First imaging took place four weeks after surgery (time point 0), then
imaging continued up to 2.5 months in a two-week interval. Imaging was performed
using an upright two-photon microscope (Zeiss), equipped with a 203 water
immersion objective (1.0 NA; Zeiss). TdTomato was excited with a femtosecond laser
(MaiTai DeepSee, Spectra-Physics) at 915 nm and emission was collected at 527–
582 nm, respectively (LSM 7MP, Zeiss). Images of cell bodies were acquired at
0.41 mm pixels resolution in xy dimension and 2 mm in z dimension (1024 3 1024
pixels). Same imaging volumes were precisely aligned over the imaging period. The
laser intensity was adjusted to keep the emitted tdTomato fluorescence stable.
Olfaction tests. To detect differences in olfactory performance, 6-month-old mice
were tested in a smell discrimination task37,38. Briefly, before the start of the
experiment, mice were placed on a restricted diet to maintain a 10% reduced body
weight during training and testing phase. Odorants were presented on fresh shavings
(1 ml per 3 g shavings) in 2 round plastic dishes, mounted horizontally on a carrier,
and separated by a vertical barrier between them. During training, the mice learned to
dig in a dish with unscented shavings to find a small piece of chocolate. For the
discrimination tasks, two identical dishes were presented simultaneously on the
carrier. In the beginning, one dish was scented with apple odorant (designated as S1;
10% Phenethylacetate; Sigma) and the other with the same amount of solvent
(Diethylphthalate; Sigma). Digging in the S1 dish was consistently rewarded with
chocolate. To train the mice to associate the smell of S1 (and not of chocolate) with the
reward, the chocolate was now buried in both scented shavings (15 successful trials).
Mice had to discriminate between S1 and strawberry odorant (S2; 10% Methyl trans-
cinnamate; Sigma). To increase the level of difficulty, the mice had to discriminate
between different binary mixtures of S1 and S2 with increasing similarity between the
odours, [S15S2] vs.[S15S2]: [70530] vs. [30570]; [55545] vs.[45555]; [53547] vs.
[47553]; [51549] vs. [49551] and [50550] vs. [50550]. A correct choice was defined as
digging in the dish with the higher amount of S1 (8 trails/day). Successful choices
were rewarded with a small piece of chocolate, whereas failed discrimination (choice
of S2) immediately terminated the trial. To assess differences in olfactory long-term
memory, the mice were confronted with the same odours again after 2 months, and
the success in choosing the S1 odour was evaluated (12 trials).
Data analysis and statistics. Quantitative analysis of neuron turnover was performed
manually from two-photon image stacks, using Zeiss AIM software. From each stack
in consecutive imaging sessions, several regions of interest were identified and
cropped. Stacks were z-projected and each region of interest was compared with the
same region in the previous session. Thereby, each cell was manually scored as stable
(Nstable), lost (Nlost), or new (Ngained). Turnover ratios representing the gain and loss
of neurons from day to day were calculated as dTOR 5 (Ngained 1 Nlost)/(2 3
Npresent)/It, where Npresent is the number of all apparent neurons at a time point and It
is the number of days between subsequent imaging sessions60. Fractional changes in
the neuron population were quantified for every time point relative to the first
imaging session. Mean fractions of stable, lost and gained neurons were calculated for
each time point and mouse. In addition, the fractions of cells which were gained at one
time-point, but immediately lost in the following, were quantified as parameter for
neuronal integration stability. Neuronal survival rates were measured at 2, 6 and 10
weeks relative to session 1. For statistical comparison of the two test groups over
various time points, we applied two-way ANOVA with Bonferroni post-hoc test. To
compare changes inside one group, we used one-way ANOVA with repeated
measures, followed by Tukey-Kramer post-hoc test. To evaluate the success rates of
both groups at various odour mixtures, we applied two-way ANOVA with Bonferroni
post-hoc test. Unpaired Student’s t-test was used to assess neuron numbers and
olfactory memory. Significance was accepted at p , 0.05. Data were illustrated as
mean 6 SEM or mean 6 SD.
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